These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38178212)

  • 1. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry.
    Buschulte K; Kabitz HJ; Hagmeyer L; Hammerl P; Esselmann A; Wiederhold C; Skowasch D; Stolpe C; Joest M; Veitshans S; Höffgen M; Maqhuzu P; Schwarzkopf L; Hellmann A; Pfeifer M; Behr J; Karpavicius R; Günther A; Polke M; Höger P; Somogyi V; Lederer C; Markart P; Kreuter M
    Respir Res; 2024 Jan; 25(1):5. PubMed ID: 38178212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registry.
    Buschulte K; Kabitz HJ; Hagmeyer L; Hammerl P; Esselmann A; Wiederhold C; Skowasch D; Stolpe C; Joest M; Veitshans S; Höffgen M; Maqhuzu P; Schwarzkopf L; Hellmann A; Pfeifer M; Behr J; Karpavicius R; Günther A; Polke M; Höger P; Somogyi V; Lederer C; Markart P; Kreuter M
    Respir Res; 2024 Mar; 25(1):113. PubMed ID: 38448953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment - a German claims data analysis.
    Wälscher J; Witt S; Schwarzkopf L; Kreuter M
    Respir Res; 2020 Mar; 21(1):73. PubMed ID: 32216792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    Salonen J; Vähänikkilä H; Purokivi M; Kaarteenaho R
    PLoS One; 2020; 15(11):e0242860. PubMed ID: 33253258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
    Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
    King CS; Ignacio RV; Khangoora V; Nyquist A; Singhal A; Thomas C; Cantres OF; Aryal S; Shlobin OA; Flaherty K; Lasky J; Nathan SD
    Am J Respir Crit Care Med; 2024 Sep; 210(6):801-813. PubMed ID: 38236191
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
    Saketkoo LA; Mittoo S; Huscher D; Khanna D; Dellaripa PF; Distler O; Flaherty KR; Frankel S; Oddis CV; Denton CP; Fischer A; Kowal-Bielecka OM; LeSage D; Merkel PA; Phillips K; Pittrow D; Swigris J; Antoniou K; Baughman RP; Castelino FV; Christmann RB; Christopher-Stine L; Collard HR; Cottin V; Danoff S; Highland KB; Hummers L; Shah AA; Kim DS; Lynch DA; Miller FW; Proudman SM; Richeldi L; Ryu JH; Sandorfi N; Sarver C; Wells AU; Strand V; Matteson EL; Brown KK; Seibold JR;
    Thorax; 2014 May; 69(5):428-36. PubMed ID: 24368713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis.
    Lobo LJ; Liu Y; Li P; Ramaswamy M; Swaminathan AC; Veeraraghavan S; Fan Y; Neely ML; Palmer SM; Olson AL;
    BMC Pulm Med; 2024 Sep; 24(1):468. PubMed ID: 39334205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
    Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ;
    Respirology; 2022 Oct; 27(10):854-862. PubMed ID: 35652240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
    Natalini JG; Diamond JM; Porteous MK; Lederer DJ; Wille KM; Weinacker AB; Orens JB; Shah PD; Lama VN; McDyer JF; Snyder LD; Hage CA; Singer JP; Ware LB; Cantu E; Oyster M; Kalman L; Christie JD; Kawut SM; Bernstein EJ
    J Heart Lung Transplant; 2021 May; 40(5):351-358. PubMed ID: 33637413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany.
    Maqhuzu PN; Schwarzkopf L; Markart P; Behr J; Holle R; Leidl R; Kreuter M
    Respiration; 2022; 101(11):1015-1023. PubMed ID: 36302347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Chung JH; Cox CW; Montner SM; Adegunsoye A; Oldham JM; Husain AN; Vij R; Noth I; Lynch DA; Strek ME
    AJR Am J Roentgenol; 2018 Feb; 210(2):307-313. PubMed ID: 29140119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.